Pacific Biosciences Of California (PACB) Change in Acquisitions & Divestments (2016 - 2026)
Pacific Biosciences Of California has reported Change in Acquisitions & Divestments over the past 16 years, most recently at $60.0 million for Q4 2025.
- For Q4 2025, Change in Acquisitions & Divestments fell 89.76% year-over-year to $60.0 million; the TTM value through Dec 2025 reached $340.1 million, down 42.75%, while the annual FY2025 figure was $340.1 million, 42.75% down from the prior year.
- Change in Acquisitions & Divestments for Q4 2025 was $60.0 million at Pacific Biosciences Of California, down from $84.6 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $585.9 million in Q4 2024 and troughed at -$343.6 million in Q3 2024.
- A 5-year average of $102.3 million and a median of $84.6 million in 2025 define the central range for Change in Acquisitions & Divestments.
- Biggest five-year swings in Change in Acquisitions & Divestments: crashed 177.44% in 2021 and later surged 5557.3% in 2022.
- Year by year, Change in Acquisitions & Divestments stood at -$10.6 million in 2021, then surged by 5557.3% to $575.8 million in 2022, then crashed by 153.93% to -$310.5 million in 2023, then skyrocketed by 288.68% to $585.9 million in 2024, then crashed by 89.76% to $60.0 million in 2025.
- Business Quant data shows Change in Acquisitions & Divestments for PACB at $60.0 million in Q4 2025, $84.6 million in Q3 2025, and $82.0 million in Q2 2025.